Of 546 live births with possible maternal Zika virus, 11 percent proved positive
FRIDAY, June 23, 2017 (HealthDay News) — Testing placental and fetal tissue after a child is born can confirm or rule out Zika infection, according to research published in the June 23 issue of the U.S. Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.
Sarah Reagan-Steiner, M.D., of the CDC’s National Center for Emerging and Zoonotic Infectious Diseases, and colleagues analyzed results of tissue testing for pregnancy-related Zika infection in all 50 states and Washington, D.C.
The team found that of 546 live births with possible maternal Zika virus exposure, 11 percent (60) proved positive. In 81 cases of pregnancy loss where tissues were available for sampling, 22 percent — or 18 — tested positive for Zika virus. In 363 births where an unidentified infection had occurred, testing was able to confirm Zika in 10 percent of babies. Zika was ruled out via placental tissue testing in another 10 percent of cases where infection likely occurred well before the mother’s blood was tested.
“Testing of placental tissues from live births can continue to be considered when results of maternal Zika virus testing are not definitive or testing is not performed within the optimal time,” the authors write.
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Addition of CAC to PREVENT-ASCVD Equations May Improve Predictive Utility in Certain Patients
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors
Biomarkers Plus Kidney Donor Profile Index Improve Prediction of Concordant Allograft Outcomes
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome
Female Emergency Medicine Physicians Order More Tests, Admit More Patients
1 in 3 Women and 1 in 4 Men Engage in Intentional Outdoor Tanning